Cargando…
Sphingolipids in cardiovascular diseases and metabolic disorders
Many investigations suggest the pivotal role of sphingolipids in the pathogenesis of lifestyle diseases such as myocardial infarction, hypertension, stroke, diabetes mellitus type 2 and obesity. Some studies suggest that sphingolipids are important factors in cellular signal transduction. They serve...
Autores principales: | Borodzicz, Sonia, Czarzasta, Katarzyna, Kuch, Marek, Cudnoch-Jedrzejewska, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470334/ https://www.ncbi.nlm.nih.gov/pubmed/26076974 http://dx.doi.org/10.1186/s12944-015-0053-y |
Ejemplares similares
-
Sphingolipid metabolism and signaling in cardiovascular diseases
por: Borodzicz-Jażdżyk, Sonia, et al.
Publicado: (2022) -
A Review of the Roles of Apelin and ELABELA Peptide Ligands in Cardiovascular Disease, Including Heart Failure and Hypertension
por: Rozwadowski, Jan, et al.
Publicado: (2022) -
The role of epidermal sphingolipids in dermatologic diseases
por: Borodzicz, Sonia, et al.
Publicado: (2016) -
Authors’ response to the letter: Takotsubo syndrome: a neurocardiac syndrome inside the autonomic nervous system
por: Borodzicz, Sonia, et al.
Publicado: (2019) -
New Peptides as Potential Players in the Crosstalk Between the Brain and Obesity, Metabolic and Cardiovascular Diseases
por: Czerwińska, Magdalena, et al.
Publicado: (2021)